Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000936392-07-000515
Filing Date
2007-06-12
Accepted
2007-06-12 16:26:58
Documents
5
Effectiveness Date
2007-06-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 a30978sv8.htm S-8 67864
2 EXHIBIT 5.1 a30978exv5w1.htm EX-5.1 4247
3 EXHIBIT 23.1 a30978exv23w1.htm EX-23.1 1692
4 EXHIBIT 99.1 a30978exv99w1.htm EX-99.1 77604
5 EXHIBIT 99.2 a30978exv99w2.htm EX-99.2 66677
  Complete submission text file 0000936392-07-000515.txt   219482
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-143677 | Film No.: 07915237
SIC: 2836 Biological Products, (No Diagnostic Substances)